KCNH1 and carcinoma: It would be worthwhile to extend these studies to determining possible effects of retigabine on invasiveness and to develop openers to other Kv’s more commonly expressed in carcinomas, e.g. Kv1.3, Kv10.1 and Kv11.1 (Sect.